Quick answers
- What is Cancidas?
- Cancidas is a brand name of Caspofungin acetate, a prescription medicine. The FDA NDC Directory lists 2 Cancidas products in 2 strengths and forms.
- Who makes Cancidas?
- Merck holds the FDA application for Cancidas (NDA021227, approved January 26, 2001).
- Is there a generic or store brand of Cancidas?
- Yes. The FDA NDC Directory lists 12 other products with the same active ingredients, strength and form as a Cancidas product, 10 of them generic. Ask your pharmacist whether one is right for you.
- Has Cancidas been recalled?
- No recall linked to Cancidas products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Cancidas is
Each Cancidas product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Caspofungin acetate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| caspofungin acetate 5 mg/mL injection, powder, lyophilized, for solution (intravenous) | Cancidas | 6 products, 6 companies | — |
| caspofungin acetate 7 mg/mL injection, powder, lyophilized, for solution (intravenous) | Cancidas | 6 products, 6 companies | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Caspofungin acetate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021227 | Merck | January 26, 2001 | 2 |
Companies that list Cancidas
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cancidas products.
- Merck Sharp & Dohme LLC2 products
Recalls
No recall linked to Cancidas products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.